Search Results - Cristina B. Guzmán

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setti

    A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia i... by Larry C. Deeb, Hélène Dulude, Cristina B. Guzmán, Shuyu Zhang, Barry Reiner, Claude A. Piché, Sheetal Pradhan, Xiaotian Michelle Zhang

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Treatment with <scp>LY</scp>2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

    Treatment with <scp>LY</scp>2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes by Cristina B. Guzmán, Xiaotian Michelle Zhang, Rong Liu, Arie Regev, Sudha S. Shankar, Parag Garhyan, Sreekumar Pillai, C Kazda, Naga Chalasani, Thomas A. Hardy

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study

    Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study by Jean‐François Yale, Hélène Dulude, Marc Egeth, Claude A. Piché, Martin Lafontaine, D. Calero Carballo, Rebecca Margolies, Emily Dissinger, Adam Shames, Nicole Kaplowitz, Michelle Xiaotian Zhang, Shuyu Zhang, Cristina B. Guzmán

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting

    Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting by Elizabeth R. Seaquist, Hélène Dulude, Xiaotian Michelle Zhang, Rémi Rabasa‐Lhoret, George Tsoukas, James Conway, S. John Weisnagel, Gregg Gerety, Vincent Woo, Shuyu Zhang, D. Calero Carballo, Sheetal Pradhan, Claude A. Piché, Cristina B. Guzmán

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma

    Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma by Steven M. Horwitz, Tatyana Feldman, Jing Christine Ye, Michael S. Khodadoust, Javier Muñoz, Paul A. Hamlin, Youn H. Kim, Ryan A. Wilcox, Manish R. Patel, Greg Coffey, A. Micheil Innes, Andreas Betz, Jaymes Holland, Cristina B. Guzmán, Sonali M. Smith

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: